Costco COO Dick DiCerchio will retire as the company’s senior executive vice president and COO. He will remain as a member of the company’s board.
QuantRX Biomedical appointed two new independent directors to its board: Robert G. Pinco, senior counsel and former head of biomedical/food and drug group at Buchanan Ingersoll & Rooney PC, and Patrick T. Mooney, CEO, president and chairman of Echo Therapeutics. The board of directors now has five members.
Peggy Gann, senior vice president of human resources and administration, has been elected as corporate executive officer of Thomas & Betts Corporation. Gann will report to Dominic J. Pileggi, chairman and CEO, and will be responsible for developing and direction the company’s global human services organization.
DEX, a supply-chain logistics provider, has added Tony Harris to its board. Harris has served as CEO of ADT PLC in the United Kingdom.
Daniel Gold has been appointed president and CEO of Marshall Edwards, a clinical developer of anti-cancer therapeutics. Gold most recently served as president and CEO of Prospect Therapeutics.
Autotask Founder and CEO Bob Godgart, has been appointed vice chairman of CompTIA’s board. Godgart directs all of Autotask’s investment and business strategy as well as operational activities.
James Ziglar was added to Integrated Biometric’s board. Ziglar is currently a senior fellow at the Migration Policy Institute where his work is focused on U.S. immigration policy, border-control and security initiatives.